Listeria monocytogenes-Induced Rhombencephalitis in a Patient With Multiple Sclerosis Treated With Dimethyl Fumarate

JAMA Neurol. 2018 Jun 1;75(6):762-763. doi: 10.1001/jamaneurol.2018.0368.

Authors

Serena Ruggieri¹, Alessandra Logoteta², Gabriella Martini³, Alessandro Bozzao⁴, Laura De Giglio¹

Affiliations

¹ Department of Neurology and Psychiatry, "Sapienza" University of Rome, Rome, Italy.
² Department of Neurosciences, Sant'Andrea Hospital, "Sapienza" University of Rome, Rome, Italy.
³ Pharmacy Unit, Sant'Andrea Hospital, Rome, Italy.
⁴ Neurosciences, Mental Health, and Sensory Organs Department, "Sapienza" University of Rome, Rome, Italy.

PMID: 29610843
DOI: 10.1001/jamaneurol.2018.0368

No abstract available

Publication types

Case Reports

MeSH terms

Adult
Dimethyl Fumarate / adverse effects*
Encephalitis / chemically induced
Encephalitis / complications
Encephalitis / diagnostic imaging*
Female
Humans
Immunosuppressive Agents / adverse effects
Listeria monocytogenes / isolation & purification*
Listeriosis / chemically induced
Listeriosis / complications
Listeriosis / diagnostic imaging*
Multiple Sclerosis / complications
Multiple Sclerosis / diagnostic imaging*
Multiple Sclerosis / drug therapy
Rhombencephalon / diagnostic imaging*
Rhombencephalon / drug effects
Treatment Outcome

Substances

Immunosuppressive Agents
Dimethyl Fumarate